BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11044091)

  • 1. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation.
    Tierney RJ; Kirby HE; Nagra JK; Desmond J; Bell AI; Rickinson AB
    J Virol; 2000 Nov; 74(22):10468-79. PubMed ID: 11044091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
    J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
    Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH
    J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5.
    Tierney R; Kirby H; Nagra J; Rickinson A; Bell A
    J Virol; 2000 Nov; 74(22):10458-67. PubMed ID: 11044090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Puglielli MT; Woisetschlaeger M; Speck SH
    J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation.
    Tierney RJ; Nagra J; Rowe M; Bell AI; Rickinson AB
    J Virol; 2015 Mar; 89(5):2483-93. PubMed ID: 25540367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter.
    Bell A; Skinner J; Kirby H; Rickinson A
    Virology; 1998 Dec; 252(1):149-61. PubMed ID: 9875325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wp specific methylation of highly proliferated LCLs.
    Park JH; Jeon JP; Shim SM; Nam HY; Kim JW; Han BG; Lee S
    Biochem Biophys Res Commun; 2007 Jun; 358(2):513-20. PubMed ID: 17499215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization.
    Yoo LI; Woloszynek J; Templeton S; Speck SH
    J Virol; 2002 Nov; 76(22):11763-9. PubMed ID: 12388739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S; Speck SH; Woisetschläger M
    J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of latent Epstein-Barr virus promoters.
    Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
    Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.
    Paulson EJ; Fingeroth JD; Yates JL; Speck SH
    Virology; 2002 Jul; 299(1):109-21. PubMed ID: 12167346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.
    Tierney R; Nagra J; Hutchings I; Shannon-Lowe C; Altmann M; Hammerschmidt W; Rickinson A; Bell A
    J Virol; 2007 Sep; 81(18):10092-100. PubMed ID: 17626071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation.
    Li H; Minarovits J
    Adv Cancer Res; 2003; 89():133-56. PubMed ID: 14587872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interaction of nuclear factor y and sp1 is required for activation of the epstein-barr virus C promoter.
    Boreström C; Zetterberg H; Liff K; Rymo L
    J Virol; 2003 Jan; 77(2):821-9. PubMed ID: 12502798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.
    Yoo L; Speck SH
    J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors.
    Kirby H; Rickinson A; Bell A
    J Gen Virol; 2000 Apr; 81(Pt 4):1057-66. PubMed ID: 10725433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
    Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
    J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.